Zostavax safety advisory

A new safety advisory regarding Zostavax vaccine has been released by the TGA reiterating that it should not be used in people with impaired immune function.

Health professionals are reminded that, on rare occasions, disseminated varicella-zoster virus (Oka vaccine strain) infection can occur in patients following administration of Zostavax vaccine hence the importance of careful prescreening and a risk-based assessment prior to Zostavax administration.